Where does Medicrea International rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medicrea International ranks #6,172 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medicrea International hold?

Medicrea International holds 55 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Medicrea International's Innovation Score?

Medicrea International has an Innovation Score of 35.4 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medicrea International focus on?

Medicrea International's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 50 patents, ranking #377 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Medicrea International's patent grant rate increasing or decreasing?

Medicrea International's recent grant velocity is -48% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medicrea International's patents?

Medicrea International's patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medicrea International patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medicrea International

USPTO PatentsView assignee record - 55 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medicrea ranks #6,172 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 7 technology areas.

#6,172
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.4/100): 15.3
avg claims per patent: -48%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6172 · Foreign Corporation #6,172 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,172/49,997
PHOTO-FINISH Laurus Labs
CPC-NARROW A61B · 7 areas
INNOV-THIN 35.4/100
CLAIMS-RICH 15.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -48% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Laurus Labs Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medicrea’s 35.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (39%) Velocity 3.0 pts (8%) Breadth 9.4 pts (26%) Claim depth 9.2 pts (26%)

Qualcomm Incorporated · highest

85
Enveil · near

35
Medicrea International · this assignee

35
Thermedical · near

35
CUB Elecparts · near

35
Tekelec · near

35
3D Lighting… · lowest

7

What this shows Medicrea's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medicrea?

Each dot is one of Medicrea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medicrea’s own 15.3 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medicrea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medicrea's grants concentrate

Medicrea International is a focused PatentsView assignee: 7 CPC subclasses with 90.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (12 grants) versus a trough of 2 in 2020. By volume, Medicrea sits between Laurus Labs Limited and Micro Focus Software Inc..

Medicrea's three-year grant acceleration

From 2019–2021 to 2022–2024, Medicrea International moved from 20 to 9 grants (0.45x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Laurus Labs

55
Liebherr-werk Nen…

55
MAG Aerospace Ind…

55
MAN Truck & Bus SE

55
Microport Orthope…

55
Mahle Filter Syst…

55
Metso Minerals

55
Micro Focus Softw…

55
Medicrea Internat… ◀

55

What this shows Medicrea holds 55 patents at rank #6,170, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medicrea

By rank, the assignees closest to #6,170 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medicrea's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medicrea, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medicrea ranks #377 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Enveil, Inc. 35 Thermedical, Inc. 35 Tekelec, Inc. 35 CUB Elecparts Inc. 35

Similar claim depth

Nearest assignees by average claims per patent (15.3 here).

Varta Microbattery GMBH 15.3 avg Federal Signal Corporation 15.3 avg Saes Getters S.P.A. 15.3 avg BEN Gurion University OF THE Negev Research AND Development Authority 15.3 avg

Medicrea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medicrea International patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	12.7%
2016	7	12.7%
2017	4	7.3%
2018	3	5.5%
2019	12	21.8%
2020	2	3.6%
2021	6	10.9%
2023	2	3.6%
2024	7	12.7%
2025partial year	5	9.1%

Which technologies does Medicrea International patent most?

A61B - DIAGNOSIS; SURGERY; Identification 50

G06T - Image Data Processing OR Generation, IN General 19

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 14

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 12

G06N - Computing Arrangements Based ON Specific Computational Models 5

G06F - Electric Digital Data Processing 4

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medicrea International's patent record in context - here's where to go next.

Medicrea International's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 90.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #6,172 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medicrea International against Laurus Labs Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.